147 related articles for article (PubMed ID: 12060465)
1. Reduction of alpha-galactosyl xenoantigen by expression of endo-beta-galactosidase C in pig endothelial cells.
Ogawa H; Kobayashi T; Yokoyama I; Nagatani N; Mizuno M; Yoshida J; Kadomatsu K; Muramatsu H; Nakao A; Muramatsu T
Xenotransplantation; 2002 Jul; 9(4):290-6. PubMed ID: 12060465
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic removal of alphaGal antigen in pig kidneys by ex vivo and in vivo administration of endo-beta-galactosidase C.
Liu D; Kobayashi T; Yokoyama I; Ogawa H; Nagasaka T; Muramatsu H; Kadomatsu K; Oikawa T; Shimano Y; Morozumi K; Uchida K; Muramatsu T; Nakao A
Xenotransplantation; 2002 May; 9(3):228-36. PubMed ID: 11983021
[TBL] [Abstract][Full Text] [Related]
3. In vivo gene transfer of endo-beta-galactosidase C removes alphaGal antigen on erythrocytes and endothelial cells of the organs.
Miki Y; Maruyama S; Liu D; Kobayashi T; Sato F; Shimizu H; Kato S; Sato W; Morita Y; Yuzawa Y; Muramatsu T; Matsuo S
Xenotransplantation; 2004 Sep; 11(5):444-51. PubMed ID: 15303981
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of endo-beta -galactosidase C and its application in removing alpha -galactosyl xenoantigen from blood vessels in the pig kidney.
Ogawa H; Muramatsu H; Kobayashi T; Morozumi K; Yokoyama I; Kurosawa N; Nakao A; Muramatsu T
J Biol Chem; 2000 Jun; 275(25):19368-74. PubMed ID: 10858461
[TBL] [Abstract][Full Text] [Related]
5. A novel glycosylation signal regulates transforming growth factor beta receptors as evidenced by endo-beta-galactosidase C expression in rodent cells.
Watanabe S; Misawa M; Matsuzaki T; Sakurai T; Muramatsu T; Sato M
Glycobiology; 2011 Apr; 21(4):482-92. PubMed ID: 21062784
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
7. Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs.
Puga Yung GL; Li Y; Borsig L; Millard AL; Karpova MB; Zhou D; Seebach JD
Xenotransplantation; 2012; 19(3):196-206. PubMed ID: 22702471
[TBL] [Abstract][Full Text] [Related]
8. Enrichment of xenograft-competent genetically modified pig cells using a targeted toxin, isolectin BS-I-B4 conjugate.
Akasaka E; Watanabe S; Himaki T; Ohtsuka M; Yoshida M; Miyoshi K; Sato M
Xenotransplantation; 2010; 17(1):81-9. PubMed ID: 20149191
[TBL] [Abstract][Full Text] [Related]
9. Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies.
Rieben R; Bovin NV; Korchagina EY; Oriol R; Nifant'ev NE; Tsvetkov DE; Daha MR; Mohacsi PJ; Joziasse DH
Glycobiology; 2000 Feb; 10(2):141-8. PubMed ID: 10642605
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of transgenic mice systemically expressing endo-beta-galactosidase C.
Watanabe S; Misawa M; Matsuzaki T; Sakurai T; Muramatsu T; Yokomine TA; Sato M
Glycobiology; 2008 Jan; 18(1):9-19. PubMed ID: 17947256
[TBL] [Abstract][Full Text] [Related]
11. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of gene transfer with endo-beta-galactosidase C on alpha-galactosyl xenoantigen expression.
Ogawa H; Kobayashi T; Yokoyama I; Liu D; Nagasaka T; Kadomatsu K; Muramatsu H; Takagi H; Muramatsu T; Nakao A
Transplant Proc; 2002 Nov; 34(7):2756. PubMed ID: 12431596
[No Abstract] [Full Text] [Related]
13. Expression of human alpha-galactosidase and alpha1,2-fucosyltransferase genes modifies the cell surface Galalpha1,3Gal antigen and confers resistance to human serum-mediated cytolysis.
Jia Y; Ren H; Gao X; Ji S; Yang J; Liu Z; Li S; Zhang Y
Chin Med Sci J; 2004 Mar; 19(1):31-7. PubMed ID: 15104222
[TBL] [Abstract][Full Text] [Related]
14. Removal of alphaGal antigens by ex vivo perfusion of pig kidneys with endo-beta-galactosidase C.
Kobayashi T; Yokoyama I; Ogawa H; Muramatsu H; Kadomatsu K; Hayashi S; Liu D; Kato T; Tokoro T; Oikawa T; Takeuchi O; Morozumi K; Takagi H; Muramatsu T; Nakao A
Transplant Proc; 2001; 33(1-2):763. PubMed ID: 11267058
[No Abstract] [Full Text] [Related]
15. Multivalent Galalpha1,3Gal-substitution makes recombinant mucin-immunoglobulins efficient absorbers of anti-pig antibodies.
Liu J; Weintraub A; Holgersson J
Xenotransplantation; 2003 Mar; 10(2):149-63. PubMed ID: 12588648
[TBL] [Abstract][Full Text] [Related]
16. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope.
Sadoulet MO; Franceschi C; Aubert M; Silvy F; Bernard JP; Lombardo D; Mas E
Glycobiology; 2007 Jun; 17(6):620-30. PubMed ID: 17374617
[TBL] [Abstract][Full Text] [Related]
17. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
Horvath-Arcidiacono JA; Porter CM; Bloom ET
Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
[TBL] [Abstract][Full Text] [Related]
18. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor.
Yazaki S; Iwamoto M; Onishi A; Miwa Y; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Hashimoto M; Oishi T; Liu D; Nagasaka T; Kuzuya T; Maruyama S; Ogawa H; Kadomatsu K; Uchida K; Nakao A; Kobayashi T
Xenotransplantation; 2009; 16(6):511-21. PubMed ID: 20042051
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Gal(alpha)1-3Gal(beta)1-4GlcNAc-R (alphaGal) expression on porcine valve endothelial cells.
Farivar RS; Filsoufi F; Adams DH
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):306-14. PubMed ID: 12579099
[TBL] [Abstract][Full Text] [Related]
20. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
Katopodis AG; Warner RG; Duthaler RO; Streiff MB; Bruelisauer A; Kretz O; Dorobek B; Persohn E; Andres H; Schweitzer A; Thoma G; Kinzy W; Quesniaux VF; Cozzi E; Davies HF; Mañez R; White D
J Clin Invest; 2002 Dec; 110(12):1869-77. PubMed ID: 12488437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
